Hetastarch

FDA Drug Profile

Hetastarch is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
Hetastarch
Sponsor
Fresenius Kabi AUT GmbH
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
HETASTARCH

Indications and Usage

INDICATIONS AND USAGE HEXTEND (6% Hetastarch in Lactated Electrolyte Injection) is indicated in the treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is not a substitute for blood or plasma.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.